Intensive five day intravenous insulin treatment combined with enteral feeding in hyperglycemic ischemic stroke patients: a feasibility study

Phase 2

Not yet recruiting

• Conditions: stroke; hyperglycemia; 10018424; 10007963

• Registration Number: NL-OMON30354
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 7

Inclusion Criteria

Supratentorial ischemic stroke last 24hrs
glucose > 7.0 mmol/l

Exclusion Criteria

cerebral hemorrhage
history with diabetes mellitus
dercrease consciousness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Glucose profiles: area under the curve (AUC) > 6.1 mmol/l and AUC <4.4 mmol/l.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>1) Time needed to perform all actions necessary for intensive insulin treatment.<br /><br>2) Adverse reactions<br /><br>a) Hypoglycemic episodes<br /><br>b) Incidence of aspiration pneumonia<br /><br>c) Infection or skin irritation at the site of tube insertion</p><br>